Related Experiment Video
Updated: Jun 12, 2025

09:42
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
7.4K
Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4-Dinitrochlorobenzene-Induced Mouse
Ye Jin Ha1, Ka Hee Tak1, Jong Lyul Lee1,2
1Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Summary
Polynucleotides (PNs) effectively treat atopic dermatitis (AD) by reducing inflammation and improving skin barrier function. This study shows PNs decrease dermatitis severity, IgE levels, and enhance filaggrin expression in an AD mouse model.
Area of Science:
- Dermatology
- Immunology
- Biochemistry
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition linked to barrier dysfunction and immune dysregulation.
- Polynucleotides (PNs) exhibit anti-inflammatory properties, but their therapeutic potential for AD is unexamined.
Purpose of the Study:
- To investigate the efficacy of Polynucleotides (PNs) in a 2,4-dinitrochlorobenzene (DNCB)-induced mouse model of atopic dermatitis (AD).
Main Methods:
- Evaluated dermatitis severity score (DSS), spleen index, serum IgE, and trans-epidermal water loss (TEWL).
- Conducted histological analyses, cytokine mRNA expression, and filaggrin protein assessment.
- Utilized immunohistochemical (IHC) staining and Western blot for protein analysis.
Main Results:
- PNs significantly reduced DSS, spleen index, serum IgE, and TEWL.
- Histopathology revealed decreased inflammation markers and improved skin structure with PNs.
- PNs upregulated filaggrin expression and downregulated key inflammatory cytokines (IL-4, IL-5, IL-13, IL-25, IL-33, TSLP).
- Combination therapy with hyaluronic acid (HA) and PNs demonstrated enhanced benefits.
Conclusions:
- Polynucleotides (PNs) show significant anti-inflammatory effects and improve skin barrier function in an AD model.
- PNs represent a promising therapeutic candidate for managing atopic dermatitis.

